Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2 DOI
Kevin Chiem, Aitor Nogales, Fernando Almazán

и другие.

Methods in molecular biology, Год журнала: 2023, Номер unknown, С. 133 - 153

Опубликована: Дек. 8, 2023

Язык: Английский

Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences DOI Creative Commons
Dorota Kamińska, Dominika Dęborska−Materkowska, Katarzyna Kościelska−Kasprzak

и другие.

Vaccines, Год журнала: 2022, Номер 10(7), С. 1068 - 1068

Опубликована: Июль 3, 2022

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome 2 (SARS-CoV-2), is associated with a robust immune response. development of systemic inflammation leads to hyperinflammatory state due cytokine release during COVID-19. emergence many new SARS-CoV-2 variants across the world deteriorates protective antiviral immunity induced after infection or vaccination. innate response crucial for determining fate COVID-19 symptomatology. T cell-mediated main factor response; moreover, initiates rapid B-cell In this paper, we present current knowledge on and We discuss mechanisms various types vaccines (nucleoside-modified, adenovirus-vectored, inactivated virus recombinant protein adjuvanted formulations). This includes specific aspects vaccination in selected patient populations altered activity (the elderly, children, pregnant women, solid organ transplant recipients, patients rheumatic diseases malignancies). also diagnostic research tools available study anti-SARS-CoV-2 cellular humoral responses.

Язык: Английский

Процитировано

21

Two years of COVID-19 pandemic: where are we now? DOI Open Access
Jinjong Myoung

The Journal of Microbiology, Год журнала: 2022, Номер 60(3), С. 235 - 237

Опубликована: Март 1, 2022

Язык: Английский

Процитировано

19

Real-time infectious disease endurance indicator system for scientific decisions using machine learning and rapid data processing DOI Creative Commons

Shivendra Dubey,

Dinesh Verma, Mahesh Kumar

и другие.

PeerJ Computer Science, Год журнала: 2024, Номер 10, С. e2062 - e2062

Опубликована: Июль 30, 2024

The SARS-CoV-2 virus, which induces an acute respiratory illness commonly referred to as COVID-19, had been designated a pandemic by the World Health Organization due its highly infectious nature and associated public health risks it poses globally. Identifying critical factors for predicting mortality is essential improving patient therapy. Unlike other data types, such computed tomography scans, x-radiation, ultrasounds, basic blood test results are widely accessible can aid in mortality. present research advocates utilization of machine learning (ML) methodologies likelihood disease like COVID-19 leveraging data. Age, LDH (lactate dehydrogenase), lymphocytes, neutrophils, hs-CRP (high-sensitivity C-reactive protein) five extremely potent characteristics that, when combined, accurately predict 96% cases. By combining XGBoost feature importance with neural network classification, optimal approach exceptional accuracy from disease, along achieving precision rate 90% up 16 days before event. studies suggested model’s excellent predictive performance practicality were confirmed through testing three instances that depended on outcome. carefully analyzing identifying patterns these significant biomarkers insightful information has obtained simple application. This study offers potential remedies could accelerate decision-making targeted medical treatments within healthcare systems, utilizing timely, accurate, reliable method.

Язык: Английский

Процитировано

2

Extracellular Vesicle-Based SARS-CoV-2 Vaccine DOI Creative Commons

Yasunari Matsuzaka,

Ryu Yashiro

Vaccines, Год журнала: 2023, Номер 11(3), С. 539 - 539

Опубликована: Фев. 24, 2023

Messenger ribonucleic acid (RNA) vaccines are mainly used as SARS-CoV-2 vaccines. Despite several issues concerning storage, stability, effective period, and side effects, viral vector widely for the prevention treatment of various diseases. Recently, vector-encapsulated extracellular vesicles (EVs) have been suggested useful tools, owing to their safety ability escape from neutral antibodies. Herein, we summarize possible cellular mechanisms underlying EV-based

Язык: Английский

Процитировано

3

A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients DOI Creative Commons
Sikai Chen, Wenxin Wei, Fengyu Huang

и другие.

Human Vaccines & Immunotherapeutics, Год журнала: 2023, Номер 19(1)

Опубликована: Янв. 2, 2023

Patients received kidney transplantation (KTR) have a low seroconversion rate after vaccination. Our objective was to compare the rates and adverse effects of additional different vaccinations in KTR patients existing studies. Databases such as PubMed, Cochrane Library, Web Science, Embase, ClinicalTrials.gov others. Three high-quality RCT were included showed no statistical difference between two vaccines (RR = 0.93[0.76,1.13]). There sexes, for men 0.93[0.69,1.25]) women 0.91[0.62,1.33]). Among there statistically significant fever 1.06[0.44,2.57]), while injection site pain 1.14[1.18,1.84]). with who vaccines. injected viral vector vaccine less painful than those mRNA vaccine.

Язык: Английский

Процитировано

2

Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern DOI Creative Commons
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya

и другие.

Journal of microbiology epidemiology immunobiology, Год журнала: 2024, Номер 101(1), С. 36 - 51

Опубликована: Март 9, 2024

Introduction. Despite the end of COVID-19 pandemic, problem vaccine prevention this disease appears highly relevant. The emergence and widespread distribution Omicron SARS-CoV-2 variant concern (VOC) its sublineages has dramatically reduced efficacy vaccination. possible approach to solving is develop a nasal live attenuated capable activating humoral, mucosal, cell-mediated immunity, providing prolonged immune response cross-protection against different VOCs. aim study was determine immunization with cold-adapted Wuhan-like D-D2 strain homologous heterologous challenges. Materials methods. conducted on an animal model coronavirus pneumonia in golden Syrian hamsters. assessed by comparing dynamics weight, viral load organs histopathological changes lungs immunized unimmunized animals. Results. Single intranasal hamsters showed high immunogenicity: seroconversion evident all provides effective protection development productive infection when challenged both ancestral virus strains related Delta (AY.122) (sublineages BA.1.1 BA.5.2) variants. Conclusion. attenuation promising strategy for vaccine.

Язык: Английский

Процитировано

0

Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2 DOI
Kevin Chiem, Aitor Nogales, Fernando Almazán

и другие.

Methods in molecular biology, Год журнала: 2023, Номер unknown, С. 133 - 153

Опубликована: Дек. 8, 2023

Язык: Английский

Процитировано

0